WildBrain Financials

WildBrain Stock Summary

WildBrain competes with Transphorm Technology, Molecular Partners, Catalyst Pharmaceuticals, Hudson Technologies, and Cementos Pacasmayo. WildBrain Ltd. develops, produces, distributes, broadcasts, and licenses television and film programs for conventional and specialty terrestrial and cablesatellite television broadcasters worldwide. WildBrain Ltd. was incorporated in 2004 and is headquartered in Halifax, Canada. DHX Media operates under Broadcasting classification in USA and is traded on BATS Exchange. It employs 443 people.

WildBrain Key Financial Ratios

Generally speaking, WildBrain's financial ratios allow both analysts and investors to convert raw data from WildBrain's financial statements into concise, actionable information that can be used to evaluate the performance of WildBrain over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that WildBrain reports annually and quarterly.

WildBrain Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining WildBrain's current stock value. Our valuation model uses many indicators to compare WildBrain value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across WildBrain competition to find correlations between indicators driving WildBrain's intrinsic value. More Info.WildBrain is one of the top stocks in return on equity category among related companies. It is one of the top stocks in return on asset category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value WildBrain by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for WildBrain's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the WildBrain's earnings, one of the primary drivers of an investment's value.

Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

If you are still planning to invest in WildBrain check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the WildBrain's history and understand the potential risks before investing.